BlackRock Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $23.9M | Sell |
616,972
-326,218
| -35% | -$12.6M | 0.02% | 468 |
|
|
2016
Q3 | $47.8M | Sell |
943,190
-17,066
| -2% | -$864K | 0.05% | 314 |
|
|
2016
Q2 | $43.6M | Sell |
960,256
-57,627
| -6% | -$2.62M | 0.04% | 325 |
|
|
2016
Q1 | $40.3M | Sell |
1,017,883
-51,416
| -5% | -$2.03M | 0.04% | 356 |
|
|
2015
Q4 | $60.5M | Buy |
1,069,299
+235,700
| +28% | +$13.3M | 0.06% | 279 |
|
|
2015
Q3 | $33.2M | Sell |
833,599
-45,036
| -5% | -$1.79M | 0.04% | 389 |
|
|
2015
Q2 | $42M | Buy |
878,635
+86,281
| +11% | +$4.12M | 0.04% | 338 |
|
|
2015
Q1 | $31.5M | Sell |
792,354
-114,481
| -13% | -$4.55M | 0.03% | 419 |
|
|
2014
Q4 | $20.3M | Sell |
906,835
-38,576
| -4% | -$862K | 0.02% | 541 |
|
|
2014
Q3 | $14.8M | Sell |
945,411
-92,418
| -9% | -$1.45M | 0.01% | 645 |
|
|
2014
Q2 | $15.4M | Sell |
1,037,829
-26,171
| -2% | -$388K | 0.01% | 641 |
|
|
2014
Q1 | $17.1M | Buy |
1,064,000
+1,019,904
| +2,313% | +$16.4M | 0.02% | 591 |
|
|
2013
Q4 | $412K | Buy |
44,096
+2,863
| +7% | +$26.8K | ﹤0.01% | 2149 |
|
|
2013
Q3 | $467K | Buy |
41,233
+1,632
| +4% | +$18.5K | ﹤0.01% | 1949 |
|
|
2013
Q2 | $530K | Buy |
+39,601
| New | +$530K | ﹤0.01% | 1778 |
|